A Case of Cryptogenic Organizing Pneumonia after Immunotherapy and Radiotherapy for a Stage IV Non-Small Cell Lung Cancer

Lung toxicity is a major challenge especially when combining immunotherapy and radiotherapy.We present the case of a patient developing a cryptogenic organizing pneumonia (COP) after a multimodality treatment for a stage IV non-small cell lung cancer (NSCLC).

Publication Details

Journal
Annals of Case Reports
Published
2024-10-23
DOI
https://doi.org/10.29011/2574-7754.102021
Primary Topic
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Case of Cryptogenic Organizing Pneumonia after Immunotherapy and Radiotherapy for a Stage IV Non-Small Cell Lung Cancer

Annals of Case Reports
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
article

A Case of Cryptogenic Organizing Pneumonia after Immunotherapy and Radiotherapy for a Stage IV Non-Small Cell Lung Cancer

article en

Abstract

Lung toxicity is a major challenge especially when combining immunotherapy and radiotherapy.We present the case of a patient developing a cryptogenic organizing pneumonia (COP) after a multimodality treatment for a stage IV non-small cell lung cancer (NSCLC).

Annals of Case ReportsVol. 9(5)
Good health and well-being
Openalex Percentile: Top 56%
Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Case of Cryptogenic Organizing Pneumonia after Immunotherapy and Radiotherapy for a Stage IV Non-Small Cell Lung Cancer · Annals of Case Reports (2024) | TGRS Research Map | TGRS